Ambrx Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ambrx Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2023.
  • Ambrx Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $9.57M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $9.57M Sep 30, 2023 10-Q 2023-11-13
Q4 2022 $11M Dec 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.